Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rβ2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells

Immunology

Volumn 106, Issue 2, 2002, Pages 267-272

  Vecchiarelli, Anna ^a   Pietrella, Donatella ^a   Bistoni, Francesco ^a   Kozel, Thomas R ^b   Casadevall, Arturo ^a,b,c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; FUNGUS ANTIGEN; GLUCURONOXYLOMANNAN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12 RECEPTOR; MONOCLONAL ANTIBODY; POLYSACCHARIDE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ENCAPSULATION; CELL FUNCTION; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TH1 CELL;

ANTIBODIES, FUNGAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, FUNGAL; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; HUMANS; IMMUNITY, CELLULAR; PHAGOCYTOSIS; POLYSACCHARIDES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; T-LYMPHOCYTES;

EID: 0036281469     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01419.x     Document Type: Article

References (34)

1. Cryptococcal meningitis in AIDS patients: An emerging opportunistic infection in Senegal
2. Cryptococcal meningitis in immunocompetent individuals
3. Polysaccharide antigens of the capsule of Cryptococcus neoformans
4. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique
5. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen
6. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans
7. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes
8. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes
9. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans
10. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes
11. Antibody-mediated effects against Cryptococcus neoformans: Evidence for interdependency and collaboration between humoral and cellular immunity
12. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anti-capsular antibody
13. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
14. Role of cytokines in T cell immunity to a pulmonary Cryptococcus neoformans infection
15. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: Involvement of IFN-gamma and its protective effect against cryptococcal infection
16. Regulation of the IL-12/IL-12R axis: A critical step in T-helper cell differentiation and effector function
17. Costimulation via TCR and IL-1 receptor reveals a novel IL-1alpha-mediated autocrine pathway of Th2 cell proliferation
18. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection
19. Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation
20. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection
21. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies
22. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A
23. Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans
24. Binding of cryptococcal polysaccharide to Cryptococcus neoformans
25. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans
26. Phagocytic killing of Candida albicans by different murine effector cells
27. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans
28. CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response
29. Disseminated cryptococcosis in man: Decreased lymphocyte transformation in response to Cryptococcus neoformans
30. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals
31. Antibody response to Cryptococcus neoformans proteins in rodents and humans
32. Serologic evidence for Cryptococcus neoformans infection in early childhood
33. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages